We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Warns Pace Tech of Multiple Quality Violations
FDA Warns Pace Tech of Multiple Quality Violations
June 10, 2005
The FDA recently issued a warning letter to Pace Tech, claiming the patient monitor manufacturer broke a number of the agency’s quality system (QS) regulations, subsequently causing the company’s devices to be adulterated under the Federal Food, Drug, and Cosmetic Act.